School of Medicine


Showing 91-100 of 1,225 Results

  • Michele Berk, Ph.D.

    Michele Berk, Ph.D.

    Associate Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development)

    Current Research and Scholarly InterestsThe focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).

  • Wendy J. Bernstein

    Wendy J. Bernstein

    Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences

    BioSenior Community Psychiatrist, Wellness Equity Alliance, Medical Director, Project ECHO and Telemedicine for Severe Mental Illness Track to support the Mental Health of SGBV survivors in Democratic Republic of Congo project. Past Associate Medical Director at Casa del Sol, specialty mental health clinic of La Clinica de la Raza in Oakland California from 2013 to July 2021. Previously at Kaiser Permanente, Northern California, from 2000 to 2013, and Contra Costa County Older Adults Clinics from 1995-2000. Graduate of McGill University Faculty of Medicine, Montreal, Canada, and Boston University Psychiatry Residency. Interests include global health, community mental health, Latinx and underserved populations, women's health, and elder care.

  • Mahendra T. Bhati

    Mahendra T. Bhati

    Clinical Professor, Psychiatry and Behavioral Sciences
    Clinical Professor, Neurosurgery

    BioDr. Bhati is an interventional psychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying language abnormalities and transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia. He was a principal investigator for the DSM-5 academic field trials, and his research experiences included roles in the first controlled clinical trials of TMS and deep brain stimulation (DBS) for treatment of depression. He was the founding Chief of Interventional Psychiatry at Stanford where he performs consultations and provides pharmacological and neuromodulatory treatments. His current research interests include studying magnetic resonance imaging and augmented reality to target TMS, vagus nerve stimulation (VNS) for treatment-resistant depression, DBS for obsessive-compulsive disorder (OCD) and depression, responsive neurostimulation (RNS) for treatment of impulse and fear-related disorders, and focused ultrasound (FUS) for treatment-resistant OCD and depression. Dr. Bhati seeks to train more providers in mental healthcare and founded a clinical fellowship in Interventional Psychiatry at Stanford.

  • Richa Bhatia, MD

    Richa Bhatia, MD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr. Bhatia is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor in the Department of Psychiatry at Stanford University School of Medicine. She leads the Adult Anxiety clinic at Stanford in Palo Alto. She is a dual Board-certified child, adolescent and adult psychiatrist with nearly two decades of clinical experience caring for patients with various psychiatric conditions. Her work has been cited in Time magazine, Scientific American, and the Atlantic, and her professional opinions have been quoted in media such as CNBC, The Guardian, U.S. News and World Report, The Wall Street Journal, and others. Dr. Bhatia served as President-Elect of Northern California Psychiatric Society and is Immediate Past President of the Association of Women Psychiatrists. She is the co-author of the chapter on Obsessive Compulsive and Related Disorders in the recent Study Guide to DSM-5 TR, a companion volume to DSM-5 TR. She is a public mental health educator and for her work in this arena, she was honored with the 2021 Jerilyn Ross Clinician Advocate Award by the Anxiety and Depression Association of America. She has also been a recipient of the Marian Butterfield award. Her other roles include serving as Section Editor for Current Opinion in Psychiatry, a Wolters Kluwer journal, for the last 8 years. She also served as Associate Editor of Current Psychiatry for 6 years. She is often invited to give talks at national, regional and local conferences and organizations.

    She takes a whole-person approach, utilizing active, empathic listening and aimed at understanding the biological, psychological, social, and other factors affecting an individual’s mental health. She integrates judicious medication management with psychotherapy. Her psychotherapy approach is informed by various evidence-based psychotherapies such as psychodynamic therapy, cognitive behavioral therapy, and mindfulness-based, self-compassion-focused interventions. Dr. Bhatia’s other professional interests include ruling out medical conditions mimicking anxiety and other psychiatric disorders, the intersection of technology and mental health, bullying prevention, and compassion and empathy cultivation- she has also authored publications on these topics.